APLS
Price
$66.89
Change
-$0.96 (-1.41%)
Updated
Feb 21, 6:59 PM EST
5 days until earnings call
AXON
Price
$263.73
Change
-$3.97 (-1.48%)
Updated
Feb 21, 6:59 PM EST
6 days until earnings call
Ad is loading...

Analysis and predictions APLS vs AXON

Header iconAPLS vs AXON Comparison
Open Charts APLS vs AXONBanner chart's image
Apellis Pharmaceuticals
Price$66.89
Change-$0.96 (-1.41%)
Volume$562.83K
CapitalizationN/A
Axon Enterprise
Price$263.73
Change-$3.97 (-1.48%)
Volume$162.12K
CapitalizationN/A
View a ticker or compare two or three
APLS vs AXON Comparison Chart

Loading...

APLSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
AXONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
APLS vs. AXON commentary
Feb 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Buy and AXON is a Hold.

COMPARISON
Comparison
Feb 22, 2024
Stock price -- (APLS: $66.90 vs. AXON: $263.73)
Brand notoriety: APLS and AXON are both not notable
APLS represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: APLS: 44% vs. AXON: 116%
Market capitalization -- APLS: $8.04B vs. AXON: $19.76B
APLS [@Biotechnology] is valued at $8.04B. AXON’s [@Aerospace & Defense] market capitalization is $19.76B. The market cap for tickers in the [@Biotechnology] industry ranges from $543.99B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $122.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B. The average market capitalization across the [@Aerospace & Defense] industry is $11.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileAXON’s FA Score has 2 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • AXON’s FA Score: 2 green, 3 red.
According to our system of comparison, AXON is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 3 TA indicator(s) are bullish while AXON’s TA Score has 4 bullish TA indicator(s).

  • APLS’s TA Score: 3 bullish, 4 bearish.
  • AXON’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AXON is a better buy in the short-term than APLS.

Price Growth

APLS (@Biotechnology) experienced а -0.73% price change this week, while AXON (@Aerospace & Defense) price change was -2.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.61%. For the same industry, the average monthly price growth was +15.40%, and the average quarterly price growth was +36.12%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +1.38%. For the same industry, the average monthly price growth was +4.63%, and the average quarterly price growth was +18.82%.

Reported Earning Dates

APLS is expected to report earnings on May 02, 2024.

AXON is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+4.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (+1.38% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
A.I.dvisor published
a Summary for APLS with price predictions.
OPEN
A.I.dvisor published
a Summary for AXON with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AXON($19.8B) has a higher market cap than APLS($8.04B). APLS YTD gains are higher at: 11.761 vs. AXON (2.086). AXON has higher annual earnings (EBITDA): 163M vs. APLS (-575.25M). AXON has more cash in the bank: 1.19B vs. APLS (452M). APLS has less debt than AXON: APLS (110M) vs AXON (712M). AXON has higher revenues than APLS: AXON (1.47B) vs APLS (273M).
APLSAXONAPLS / AXON
Capitalization8.04B19.8B41%
EBITDA-575.25M163M-353%
Gain YTD11.7612.086564%
P/E RatioN/A134.56-
Revenue273M1.47B19%
Total Cash452M1.19B38%
Total Debt110M712M15%
FUNDAMENTALS RATINGS
APLS vs AXON: Fundamental Ratings
APLS
AXON
OUTLOOK RATING
1..100
4114
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
3712
SMR RATING
1..100
9969
PRICE GROWTH RATING
1..100
5015
P/E GROWTH RATING
1..100
10056
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APLS's Valuation (83) in the Medical Distributors industry is in the same range as AXON (90) in the Biotechnology industry. This means that APLS’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (12) in the Biotechnology industry is in the same range as APLS (37) in the Medical Distributors industry. This means that AXON’s stock grew similarly to APLS’s over the last 12 months.

AXON's SMR Rating (69) in the Biotechnology industry is in the same range as APLS (99) in the Medical Distributors industry. This means that AXON’s stock grew similarly to APLS’s over the last 12 months.

AXON's Price Growth Rating (15) in the Biotechnology industry is somewhat better than the same rating for APLS (50) in the Medical Distributors industry. This means that AXON’s stock grew somewhat faster than APLS’s over the last 12 months.

AXON's P/E Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for APLS (100) in the Medical Distributors industry. This means that AXON’s stock grew somewhat faster than APLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLSAXON
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
56%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
89%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
69%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
69%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Ad is loading...
APLSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
AXONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RCG1.600.02
+1.10%
RENN Fund
SCHY24.370.04
+0.16%
Schwab International Dividend Equity ETF
SPDN12.88N/A
N/A
Direxion Daily S&P 500® Bear 1X ETF
IGSB51.07-0.04
-0.08%
iShares 1-5 Year invmt Grd Corp Bd ETF
MBSD20.22-0.06
-0.30%
FlexShares Disciplined Duration MBS ETF